Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic

Atsushi Kusumoto1, Masaaki Miyata, Takuro Kubozono

  • 1Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan.

Journal of Cardiology
|January 24, 2012
PubMed

Insights

Highly sensitive cardiac troponin T (hs-TnT) correlates with cardiac dysfunction in heart failure patients. Elevated hs-TnT may indicate ongoing myocardial injury, impacting cardiac function and predicting outcomes.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Cardiac troponin T is a known marker for cardiomyocyte injury and predictor of adverse outcomes in chronic heart failure.
  • The clinical significance of highly sensitive cardiac troponin T (hs-TnT) in assessing cardiac dysfunction remains less understood.

Purpose of the Study:

  • To evaluate the correlation between hs-TnT levels and echocardiographic parameters in heart failure patients.
  • To assess the relationship between hs-TnT and natriuretic peptide levels in individuals with heart failure.

Main Methods:

  • Analysis of 283 out- or in-patients with B-type natriuretic peptide (BNP) ≥20 pg/mL and echocardiography.
  • Simultaneous measurement of hs-TnT, BNP, N-terminal pro-BNP (NT-proBNP), creatinine, and echocardiographic parameters including LVEF and Tei indices.
  • Linear and multiple variable regression analyses to determine independent correlations.

Main Results:

  • Hs-TnT demonstrated significant correlations with multiple echocardiographic parameters, including left ventricular ejection fraction (LVEF), E/E', and right ventricular (RV) Tei index.
  • Hs-TnT independently correlated with LVEF, E/E', RV Tei index, and estimated glomerular filtration rate (eGFR).
  • Strong correlations were observed between hs-TnT and both BNP and NT-proBNP levels, independent of age, sex, and eGFR.

Conclusions:

  • Hs-TnT levels are significantly correlated with echocardiographic indicators of cardiac dysfunction in heart failure.
  • Elevated hs-TnT in heart failure patients may reflect ongoing, minor myocardial injury contributing to cardiac dysfunction.
  • Hs-TnT serves as a valuable biomarker for assessing cardiac dysfunction and potential myocardial injury in heart failure management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...